ColoSense®
FDA premarket approval P230001/S009 · decided 2025-09-15
Approval details
- PMA number
- P230001
- Supplement
- S009
- Supplement type
- Real-Time Process
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- ColoSense®
- Generic name
- System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection
- Applicant
- Geneoscopy, Inc.
- Date received
- 2025-07-16
- Decision date
- 2025-09-15
- Days to decision
- 61 days
- Decision code
- APPR
- Product code
- SBB
- Advisory committee
- Pathology
- Expedited review
- No
- Location
- St. Louis, MO
- Statement
- Submission is approved.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.